Cases 21 - 30 of 58
AbbVie Inc. v. Prinston Pharmaceutical Inc. et al
as 1:2023cv00607
Plaintiff:
AbbVie Inc.
Defendant:
Prinston Pharmaceutical Inc., Zhejiang Huahai Pharmaceutical Co., Ltd. and Solco Healthcare US, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Prinston Pharmaceutical Inc. et al
as 1:2023cv00470
Plaintiff:
AbbVie Inc.
Defendant:
Prinston Pharmaceutical Inc., Zhejiang Huahai Pharmaceutical Co., Ltd. and Solco Healthcare US, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie, Inc. v. Teva Pharmaceuticals, Inc.
as 1:2023cv00374
Plaintiff:
AbbVie Inc.
Defendant:
Teva Pharmaceuticals Industries Ltd. and Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie, Inc. v. Teva Pharmaceuticals, Inc.
as 1:2023cv00362
Plaintiff:
AbbVie Inc.
Defendant:
Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
AbbVie Inc. v. Hetero Labs Limited et al
as 1:2023cv00448
Plaintiff:
AbbVie Inc.
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan, Inc. et al v. Mankind Pharma Ltd.
as 1:2023cv00272
Plaintiff:
Allergan, Inc.
Counter Defendant:
AbbVie Inc.
Defendant:
Mankind Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2023cv00133
Plaintiff:
AbbVie Inc.
Defendant:
Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Dr. Reddys Laboratories, Ltd. et al
as 1:2020cv00968
Plaintiff:
Genentech, Inc. and AbbVie Inc.
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271
AbbVie Inc. et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2020cv01009
Plaintiff:
Genentech, Inc. and AbbVie Inc.
Defendant:
Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. and Alembic Global Holding SA
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
